Caricamento...
The PI3K/Akt/mTOR pathway in ovarian cancer: therapeutic opportunities and challenges
The phosphatidylinositol 3 kinase (PI3K) pathway is frequently altered in cancer, including ovarian cancer (OC). Unfortunately, despite a sound biological rationale and encouraging activity in preclinical models, trials of first-generation inhibitors of mammalian target of rapamycin (mTOR) in OC hav...
Salvato in:
| Pubblicato in: | Chin J Cancer |
|---|---|
| Autori principali: | , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Sun Yat-sen University Cancer Center
2015
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4302085/ https://ncbi.nlm.nih.gov/pubmed/25556614 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5732/cjc.014.10289 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|